Newscast – Page 77 – media

Amazon focusing to upend healthcare sector with Alexa

The team is focusing to make Alex, the voice assistant, more convenient and useful in the health-care sector, which requires regulations and data privacy set by the HIPAA – Health Insurance Portability and Accountability Act. The experts are aiming to work on diabetes management, assistance for mother, infants and the elderly.
- Source: Ddu
- 707
- May 11, 2018
Company Insights digital health mHealth
Faron shares almost crashed 90% on Traumakine failure

Finland pharmaceuticals company Faron (AIM: FARN) has crashed almost 90% of its shares, as the company announced the Phase III INTEREST trial of traumakine failed to meet its efficacy endpoint.
- Source: Ddu
- 681
- May 11, 2018
COPD Researches
Lodo Therapeutics Corporation Forms Multi-Target Strategic Collaboration with Genentech

Lodo Therapeutics Corporation, a drug discovery and development company focused on identifying and producing unique, bioactive natural products directly from the microbial DNA sequence information contained in soil, today announced that it has formed a strategic drug discovery collaboration with Genentech, a member of the Roche Group.
- Source: pharmalive
- 646
- May 11, 2018
Genentech Roche
Janssen Closes in on Seeking FDA Approval for Ketamine-Based Depression Treatment

Janssen Pharmaceuticals is eying a potential breakthrough in treating refractory major depressive disorder. The company plans to seek regulatory approval for its ketamine-based esketamine nasal spray this year and if given the green light it will be the first new approach for the indication in nearly 50 years.
- Source: biospace
- 579
- May 11, 2018
depressive disorder Janssen
Safer HIV drugs taken off the shelf by Gilead

It has been stated by the patients that Gilead concealed crucial information that the TDF drugs could trigger kidney and bone risks. A safer alternative in the form of TAF could have been incorporated while marketing Truvada and Atripla. The research into TAF was deliberately stopped and the drugs are not likely to be brought to the shelf in the near future.
- Source: drugdu
- 862
- May 11, 2018
Company Insights Gilead HIV
New Ebola outbreak declared in Democratic Republic of the Congo

The Government of the Democratic Republic of the Congo declared a new outbreak of Ebola virus disease (EVD) in Bikoro in Equateur Province today (8 May). The outbreak declaration occurred after laboratory results confirmed two cases of EVD.
- Source: WHO
- 591
- May 10, 2018
Ebola Researches
U.S Doctor trust Biogen and Bristol-Myers Squibb

The questionnaire raised queries on the basis of key parameters like empathy for healthcare providers, quality content and motivation for patients. However, qualities like credible scientific content and values not related to promotional activities emerged as strong criterion for building trust.
- Source: fiercepharma
- 665
- May 10, 2018
digital health Market Views Researches
MiMedx shares falls by 20%

The US-Based MiMedx group's (a manufacturer of regenerative medicine) shares fell 20% after the federal prosecutors charged three healthcare professional for accepting bribes from Mimedx. Of these shares, 7.5% recovered when closing for the day.
- Source: drugdu
- 494
- May 10, 2018
Company Insights
Funds of £1.5 million raised by UK-based life sciences group

With a view to augment business activities and help improve product outreach; a UK-based life sciences firm has raised £1.5 million.
- Source: drugdu
- 828
- May 10, 2018
antibody Company Insights
AstraZeneca continues yard-sale strategy with $538M Seroquel rights deal

AstraZeneca is back at it again with asset sales. The company, which has taken some flak for a series of deals to offload asset rights, inked an agreement with Luye Pharma for legacy antipsychotic Seroquel and an extended-release version.
- Source: fiercepharma
- 677
- May 10, 2018
AstraZeneca Seroquel

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.